Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

Clinical trial NCT00841113 · COMPLETED

Trial details

NCT number: NCT00841113
Sponsor: Speciality European Pharma Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 1999-01-01
Primary completion: 2001-02-01
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.